Nuvation Bio Inc. (NUVB)

USD 1.98

(0.51%)

Gross Profit Summary of Nuvation Bio Inc.

  • Nuvation Bio Inc.'s latest annual gross profit in 2023 was -222 Thousand USD , up 54.13% from previous year.
  • Nuvation Bio Inc.'s latest quarterly gross profit in 2024 Q2 was -156 Thousand USD , down -168.97% from previous quarter.
  • Nuvation Bio Inc. reported a annual gross profit of -484 Thousand USD in annual gross profit 2022, down -31.52% from previous year.
  • Nuvation Bio Inc. reported a annual gross profit of -368 Thousand USD in annual gross profit 2021, down -257.28% from previous year.
  • Nuvation Bio Inc. reported a quarterly gross profit of -156 Thousand USD for 2024 Q2, down -168.97% from previous quarter.
  • Nuvation Bio Inc. reported a quarterly gross profit of -39 Thousand USD for 2023 Q1, up 63.21% from previous quarter.

Annual Gross Profit Chart of Nuvation Bio Inc. (2023 - 2018)

Historical Annual Gross Profit of Nuvation Bio Inc. (2023 - 2018)

Year Gross Profit Gross Profit Growth
2023 -222 Thousand USD 54.13%
2022 -484 Thousand USD -31.52%
2021 -368 Thousand USD -257.28%
2020 -103 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%

Peer Gross Profit Comparison of Nuvation Bio Inc.

Name Gross Profit Gross Profit Difference
ADC Therapeutics SA 67.02 Million USD 100.331%
Alto Neuroscience, Inc. -373 Thousand USD 40.483%
Annovis Bio, Inc. - USD Infinity%
Biohaven Pharmaceutical Holding Company Ltd. -3.36 Million USD 93.411%
Ginkgo Bioworks Holdings, Inc. 197.45 Million USD 100.112%
Nuvation Bio Inc. -222 Thousand USD -0.0%
Arcus Biosciences, Inc. -223 Million USD 99.9%
Zymeworks Inc. -66.97 Million USD 99.669%